tiprankstipranks
Trending News
More News >
Harmony Biosciences Holdings, Inc. (HRMY)
:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Ratios

Compare
263 Followers

Harmony Biosciences Holdings Ratios

HRMY's free cash flow for Q4 2024 was $0.73. For the 2024 fiscal year, HRMY's free cash flow was decreased by $ and operating cash flow was $0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.31 2.75 5.07 5.29 1.95
Quick Ratio
3.27 2.72 5.02 5.21 1.93
Cash Ratio
2.59 1.90 3.09 4.36 1.70
Solvency Ratio
0.50 0.44 0.76 0.22 -0.13
Operating Cash Flow Ratio
1.26 1.34 1.83 1.83 -0.02
Short-Term Operating Cash Flow Coverage
13.53 14.63 72.23 49.28 0.00
Net Current Asset Value
$ 239.21M$ 106.61M$ 129.25M$ 37.50M$ -67.00M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.24 0.28 0.44 0.45
Debt-to-Equity Ratio
0.02 0.41 0.48 1.03 2.00
Debt-to-Capital Ratio
0.02 0.29 0.32 0.51 0.67
Long-Term Debt-to-Capital Ratio
0.00 0.28 0.32 0.50 0.67
Financial Leverage Ratio
1.52 1.74 1.67 2.32 4.39
Debt Service Coverage Ratio
5.54 4.57 12.47 3.99 -0.47
Interest Coverage Ratio
10.91 8.08 7.67 2.87 0.13
Debt to Market Cap
<0.01 0.10 0.06 0.08 0.09
Interest Debt Per Share
0.59 3.65 3.50 3.75 3.91
Net Debt to EBITDA
-1.87 -0.53 -0.36 -0.40 -22.72
Profitability Margins
Gross Profit Margin
78.06%79.17%80.93%81.82%82.64%
EBIT Margin
29.28%33.87%27.45%20.17%10.63%
EBITDA Margin
32.66%38.06%32.79%34.82%0.95%
Operating Profit Margin
26.70%32.99%27.45%22.49%2.30%
Pretax Profit Margin
26.84%29.79%23.91%12.25%-23.13%
Net Profit Margin
20.36%22.14%41.44%11.33%-32.46%
Continuous Operations Profit Margin
20.36%22.14%41.44%11.33%-23.13%
Net Income Per EBT
75.86%74.31%173.35%92.44%140.36%
EBT Per EBIT
100.51%90.30%87.10%54.48%-1004.46%
Return on Assets (ROA)
14.56%15.88%26.93%7.98%-12.14%
Return on Equity (ROE)
22.07%27.59%45.05%18.55%-53.36%
Return on Capital Employed (ROCE)
23.16%29.65%20.20%18.10%1.26%
Return on Invested Capital (ROIC)
17.22%21.53%34.90%16.64%1.76%
Return on Tangible Assets
16.42%19.11%35.38%11.95%-19.59%
Earnings Yield
7.43%6.71%5.57%1.41%-2.52%
Efficiency Ratios
Receivables Turnover
8.61 7.85 8.00 8.77 7.20
Payables Turnover
11.41 6.84 22.05 55.46 10.85
Inventory Turnover
21.79 22.61 19.43 12.53 7.26
Fixed Asset Turnover
568.60 1.57K 764.14 372.49 170.30
Asset Turnover
0.72 0.72 0.65 0.70 0.37
Working Capital Turnover Ratio
2.07 1.91 1.59 1.70 2.28
Cash Conversion Cycle
27.17 9.26 47.87 64.19 67.34
Days of Sales Outstanding
42.40 46.49 45.63 41.64 50.67
Days of Inventory Outstanding
16.75 16.15 18.79 29.14 50.31
Days of Payables Outstanding
31.99 53.38 16.55 6.58 33.63
Operating Cycle
59.16 62.64 64.42 70.78 100.98
Cash Flow Ratios
Operating Cash Flow Per Share
3.86 3.69 2.44 1.71 -0.05
Free Cash Flow Per Share
3.84 3.68 1.76 -0.03 -0.09
CapEx Per Share
0.02 <0.01 0.68 1.74 0.04
Free Cash Flow to Operating Cash Flow
0.99 1.00 0.72 -0.02 1.67
Dividend Paid and CapEx Coverage Ratio
190.65 703.16 3.60 0.98 -1.49
Capital Expenditure Coverage Ratio
190.65 703.16 3.60 0.98 -1.49
Operating Cash Flow Coverage Ratio
13.53 1.13 0.75 0.51 -0.02
Operating Cash Flow to Sales Ratio
0.31 0.38 0.33 0.32 -0.02
Free Cash Flow Yield
11.17%11.40%3.20%-0.07%-0.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.45 14.91 17.97 70.91 -39.66
Price-to-Sales (P/S) Ratio
2.74 3.30 7.45 8.03 12.87
Price-to-Book (P/B) Ratio
2.97 4.11 8.09 13.15 21.16
Price-to-Free Cash Flow (P/FCF) Ratio
8.95 8.77 31.26 -1.41K -412.39
Price-to-Operating Cash Flow Ratio
8.90 8.76 22.57 24.89 -688.98
Price-to-Earnings Growth (PEG) Ratio
0.75 -0.51 0.04 -0.43 0.63
Price-to-Fair Value
2.97 4.11 8.09 13.15 21.16
Enterprise Value Multiple
6.51 8.14 22.35 22.66 1.34K
EV to EBITDA
6.51 8.14 22.35 22.66 1.34K
EV to Sales
2.13 3.10 7.33 7.89 12.66
EV to Free Cash Flow
6.95 8.23 30.76 -1.38K -405.50
EV to Operating Cash Flow
6.92 8.22 22.21 24.46 -677.46
Tangible Book Value Per Share
9.60 5.55 4.09 0.74 -1.15
Shareholders’ Equity Per Share
11.59 7.85 6.81 3.24 1.71
Tax and Other Ratios
Effective Tax Rate
0.24 0.26 -0.73 0.08 -0.40
Revenue Per Share
12.56 9.79 7.40 5.31 2.81
Net Income Per Share
2.56 2.17 3.07 0.60 -0.91
Tax Burden
0.76 0.74 1.73 0.92 1.40
Interest Burden
0.92 0.88 0.87 0.61 -2.17
Research & Development to Revenue
0.20 0.13 0.16 0.10 0.12
SG&A to Revenue
0.15 0.16 0.19 0.21 0.25
Stock-Based Compensation to Revenue
0.06 0.05 0.06 0.05 0.03
Income Quality
1.51 1.70 0.80 2.85 0.08
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis